Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Baicalin Reactivates Adult Ocular Dominance Plasticity
2026-08-27
A 2026 NeuroImage study reports that Baicalin reactivated ocular dominance plasticity and restored visual acuity in adult mice with amblyopia when combined with reverse suturing. Imaging, electrophysiology, and pharmacological blockade indicate that reduced GABAergic inhibition and perineuronal-net expression may help reopen visual-cortical plasticity.
-
Mianserin HCl: Applied Research Workflows
2026-08-27
Mianserin HCl gives researchers a practical way to interrogate 5-HT2-mediated signaling, exposure–response relationships, and formulation-dependent cytotoxicity in one experimental framework. This workflow-focused guide covers assay setup, β-cyclodextrin comparisons, antipathogenic model design, and troubleshooting for reproducible results.
-
Arsenic Neurotoxicity, BBB Disruption, and MMP-2/-9
2026-08-26
This study connects sodium arsenite-induced cognitive impairment in male mice with MMP-2/MMP-9-associated blood–brain barrier disruption, tight-junction loss, and hippocampal neuronal apoptosis. Its doxycycline hyclate intervention provides pharmacological evidence that MMP activity is a modifiable component of arsenic neurotoxicity, while also highlighting the limits of interpreting a broad MMP inhibitor as a selective mechanistic probe.
-
UHRF1, 5-mC, and Osteogenesis in Osteoporosis
2026-08-26
The reference study connects UHRF1-dependent DNA 5-methylcytosine remodeling with super-enhancer redistribution and TGM2-regulated autophagic flux in senile osteoporosis. Its multi-omics and functional validation framework identifies an epigenetic mechanism that limits MSC osteogenesis and suggests a testable route for studying age-related bone loss.
-
Chloramphenicol A2512: Reliable Lab Workflows
2026-08-25
Chloramphenicol (SKU A2512) supports controlled plasmid selection and antimicrobial workflows while requiring careful interpretation in cell viability and cytotoxicity assays. This scenario-based guide connects mechanism, formulation, storage, assay controls, and resistance-gene research to practical laboratory decisions.
-
WTAP, m6A, and MYC in Acute Myeloid Leukemia
2026-08-25
This study identifies elevated WTAP as an independent poor-risk feature in acute myeloid leukemia and connects WTAP depletion with altered m6A modification of MYC mRNA. Its combination of clinical protein analysis, functional knockdown experiments, transcriptomics, m6A-RIP, and RNA stability testing provides a framework for studying epitranscriptomic control of AML biology.
-
RQ3025 and Broad-Spectrum SARS-CoV-2 Vaccination
2026-08-24
Lu et al. characterize RQ3025, a mutation-aware bivalent mRNA vaccine designed to broaden neutralization across SARS-CoV-2 variants. Across mouse, hamster, and rat models, the vaccine induced broad antibody responses, supported protection in rats, promoted a Th1-biased cellular response, and showed no evident organ pathology after high-dose administration.
-
Lipo3K Transfection Reagent for Kidney Organoids
2026-08-24
Lipo3K Transfection Reagent enables practical DNA, siRNA, and co-transfection workflows for kidney models, including challenging organoid-derived cells. This guide translates a DDIT4-centered microplastic nephrotoxicity study into reproducible assay design, optimization, and troubleshooting strategies.
-
Batimastat (BB-94) in MMP Assays and Cancer Research
2026-08-23
Batimastat (BB-94) is a broad-spectrum hydroxamate MMP inhibitor for dissecting protease-dependent tumor invasion, angiogenesis, and extracellular signaling. This workflow also shows how carefully controlled MMP inhibition can extend neuromuscular-junction studies without confusing exploratory synapse biology with validated cancer-model evidence.
-
Sabutoclax: Separating Growth Arrest from Cell Death
2026-08-22
Sabutoclax is a pan-Bcl-2 inhibitor whose apparent potency can reflect both proliferation arrest and apoptosis. This guide applies a phenotype-first framework to improve assay interpretation, endpoint selection, and translational decision-making.
-
T-5224: AP-1 Selectivity and Ferroptosis
2026-08-22
T-5224 is a selective C-Fos/AP-1 inhibitor for dissecting inflammatory, osteoclastogenic, and cancer-cell pathways. This article connects established arthritis pharmacology with new evidence that AP-1 blockade can promote ferroptosis through PI3K/AKT signaling, while translating those findings into practical assay decisions.
-
RNASEH1-AS1 in Hepatocellular Carcinoma
2026-08-21
A 2024 study integrates TCGA analysis, prognostic modeling, and cellular validation to characterize RNASEH1-AS1 as an oncogenic lncRNA associated with poor hepatocellular carcinoma outcomes. Its findings connect RNASEH1-AS1 expression with tumor grade, immune infiltration, co-expressed RNA-processing genes, and DKC1-dependent RNA stability, while also defining important limits for clinical translation.
-
RNASEH1-AS1 in Hepatocellular Carcinoma: Study Insights
2026-08-20
The reference study integrates TCGA-based transcriptomic analysis, prognostic modeling, and laboratory validation to identify RNASEH1-AS1 as an oncogenic lncRNA associated with hepatocellular carcinoma progression. Its findings connect RNASEH1-AS1 expression with tumor grade, survival, immune infiltration, and DKC1-dependent RNA stability, while also defining a four-gene risk model for further evaluation.
-
PVT1–HIF-1α Feedback in Pancreatic Cancer
2026-08-20
The 2021 reference study identifies a reciprocal regulatory loop in which the lncRNA PVT1 enhances HIF-1α transcription and protein regulation in pancreatic cancer. Its integrated expression, promoter, RNA–protein interaction, and functional assays provide a mechanistic framework for understanding how hypoxia-associated signaling may sustain tumor progression.
-
Q-VD(OMe)-OPh in Multimodal Cell Death Studies
2026-08-19
Q-VD(OMe)-OPh is a broad-spectrum caspase inhibitor for dissecting apoptosis alongside ferroptosis and autophagy. This guide translates findings from cetuximab-resistant colorectal cancer research into practical assay and interpretation strategies.